نتایج جستجو برای: hepatic steatosis

تعداد نتایج: 96632  

Journal: :American journal of physiology. Endocrinology and metabolism 2013
Masateru Ushio Yoshihiko Nishio Osamu Sekine Yoshio Nagai Yasuhiro Maeno Satoshi Ugi Takeshi Yoshizaki Katsutaro Morino Shinji Kume Atsunori Kashiwagi Hiroshi Maegawa

Nonalcoholic fatty liver disease is the most frequent liver disease. Ezetimibe, an inhibitor of intestinal cholesterol absorption, has been reported to ameliorate hepatic steatosis in human and animal models. To explore how ezetimibe reduces hepatic steatosis, we investigated the effects of ezetimibe on the expression of lipogenic enzymes and intestinal lipid metabolism in mice fed a high-fat o...

2015
Annayya R. Aroor Javad Habibi David A. Ford Ravi Nistala Guido Lastra Camila Manrique Merlow M. Dunham Kaitlin D. Ford John P. Thyfault Elizabeth J. Parks James R. Sowers R. Scott Rector

Novel therapies are needed for treating the increasing prevalence of hepatic steatosis in Western populations. In this regard, dipeptidyl peptidase-4 (DPP-4) inhibitors have recently been reported to attenuate the development of hepatic steatosis, but the potential mechanisms remain poorly defined. In the current study, 4-week-old C57Bl/6 mice were fed a high-fat/high-fructose Western diet (WD)...

2017
Amiya P. Sinha-Hikim Indrani Sinha-Hikim Theodore C. Friedman

Non-alcoholic fatty liver disease (NAFLD) poses a serious health hazard affecting 20-40% of adults in the general population in the USA and over 70% of the obese and extremely obese people. In addition to obesity, nicotine is recognized as a risk factor for NAFLD, and it has been reported that nicotine can exaggerate obesity-induced hepatic steatosis. The development of NAFLD has serious clinic...

2013
Michael JJ Chu Anna J Dare Adam SJR Bartlett Anthony RJ Phillips Anthony JR Hickey

Background: The impact of hepatic steatosis on bioenergetics following hepatic ischemia-reperfusion injury (IRI) remains controversial and is associated with variable reports on its outcome. Large numbers of studies have been published examining the relationship between hepatic steatosis and cellular bioenergetics following hepatic IRI. This systematic review evaluates these studies. Methods: A...

2016
Hong Deng Chun-Ling Wang Jing Lai Su-Lin Yu Dong-Ying Xie Zhi-Liang Gao

BACKGROUND Chronic hepatitis B (CHB) remains a major public health problem worldwide, and the prevalence of CHB patients with hepatic steatosis is gradually increasing. Noninvasive approaches for the assessment of hepatic steatosis have been developed as alternatives to liver biopsy. OBJECTIVES This study evaluated the diagnostic performance of the fat attenuation parameter (FAP) measured by ...

2018
Qin Yi Puyang Sun Juan Li Siming Kong Jinying Tian Xuechen Li Yanan Yang Peicheng Zhang Yuying Liu Jingyan Han Xiaolin Zhang Fei Ye

The prevalence of non-alcoholic fatty liver disease (NAFLD), which is developed from hepatic steatosis, is increasing worldwide. However, no specific drugs for NAFLD have been approved yet. To observe the effects of Rho, a fraction from Rhodiola crenulate, on non-alcoholic hepatic steatosis, three mouse models with characteristics of NAFLD were used including high-fat diet (HFD)-induced obesity...

2017
Mariana Cavalheiro Magri Thamiris Vaz Gago Prata Caroline Manchiero Bianca Peixoto Dantas Celso Carmo Mazza Fátima Mitiko Tengan

BACKGROUND In chronic hepatitis C, the fibrosis progression rates are extremely variable and can be influenced by factors associated with the host, virus and environment. Among the associated metabolic factors, hepatic steatosis is characterized by an accumulation of triglycerides in hepatocytes. In the host, genetic determinants of hepatic steatosis are observed, such as single-nucleotide poly...

2017
Jeong Hoon Pan Yejin Lim Jun Ho Kim Wan Heo Ki Yong Lee Hye Ji Shin Jae Kyeom Kim Jin Hyup Lee Young Jun Kim

Alcohol-induced hepatic steatosis and inflammation are key drivers of alcohol-induced liver injury, mainly caused by oxidative stress. The roots bark of Ulmus davidiana var. japonica is well known for its substantial antioxidative and antitumorigenic potency. In this study, we examined whether this plant can ameliorate alcohol-induced liver injuries characterized by hepatic steatosis and inflam...

2015
Rafat A. Siddiqui Zhidong Xu Kevin A. Harvey Thomas M. Pavlina Michael J. Becker Gary P. Zaloga

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in developed countries. NAFLD encompasses a spectrum of diseases, ranging from hepatic steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis, and liver failure. The etiology of NAFLD remains unclear but is thought to relate to increased fatty acid flux within the liver that results in t...

2017
Mikolaj Ogrodnik Satomi Miwa Tamar Tchkonia Dina Tiniakos Caroline L Wilson Albert Lahat Christoper P Day Alastair Burt Allyson Palmer Quentin M Anstee Sushma Nagaraja Grellscheid Jan H J Hoeijmakers Sander Barnhoorn Derek A Mann Thomas G Bird Wilbert P Vermeij James L Kirkland João F Passos Thomas von Zglinicki Diana Jurk

The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction. Senescent cells contribute to age-related tissue degeneration. Here we show that the accumulation of senescent cells promotes hepatic fat accumulation and ste...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید